Corporate Ambassador Program

 

 

CAP provides forward-thinking companies with opportunities for strategic collaboration to advance the specialty, inform the future of IR and be recognized for their support of the field. SIR and SIR Foundation are grateful for the CAP partner companies that invest in the specialty and help make our missions possible.

 

 

 

---

Please join us in thanking our current CAP partners:

 

VANGUARD
Boston Scientific Corporation
Varian

 

LEADER
Medtronic

 

ADVOCATE
AngioDynamics
BD
Cook Medical
Gore & Associates
Guerbet
Penumbra
Siemens Healthineers
Sirtex Medical

 

ASSOCIATE
Abbott Vascular
Argon Medical Devices
Bristol-Myers Squibb
Cordis, A Cardinal Health company
Dova Pharmaceuticals
Eisai, Inc.
Theragenics® Interventional/Galt Medical
GI Supply, Inc.
Inari Medical
Philips Healthcare
Stryker IVS
Terumo Interventional Systems
United Biologics, Inc.

The Corporate Impact Report recognizes the power of corporate investments to advance critical initiatives that strengthen the field of IR.

Click to view the report

 

There is unlimited range to what SIR and SIR Foundation can do with the help of deeply engaged partners.

The Corporate Impact Report highlights strategic initiatives where industry support has added constructive value to our members, our sector and our cause. In the Impact Report, we recognize the ways forward-thinking investments in IR allow the society to achieve major milestones and foster a community marked by clinical excellence.